Skip to content
Wenlo
Sign in
← Markets

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. (REGN) — Form 144: Proposed sale of shares

144REGNFiled Nov 16, 2026, 11:26 AM ET

AI-generated summary

Director GEORGE L. SING filed a notice of proposed sale for 1,000 shares of Common stock with an aggregate market value of $960,264.40 through Morgan Stanley Smith Barney LLC Executive Financial Services. The sale is approximated to occur on November 16, 2026. The shares were originally acquired on April 9, 1991, through a private acquisition from the issuer or affiliate.

Key facts

Seller
GEORGE L. SING
Relationship
Director
Shares to sell
1,000
Market value
$960,264.40
Approximate sale date
Nov 16, 2026
Broker
Morgan Stanley Smith Barney LLC Executive Financial Services
Acquired
Apr 9, 1991 · Private Acquisition from Issuer/Affiliate

More REGN filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.